YIDU TECH (02158) buys back for nine consecutive days, breaking ten million in a single day again, with continuous increase in southbound funds.

On February 5th, YIDU TECH (02158) issued another share repurchase announcement. The company repurchased approximately 1.88 million shares at a price of around HK$5.55 per share on the same day, totaling over HK$10 million in expenditure. This marks the ninth consecutive trading day of intensive repurchases, with a cumulative expenditure of around HK$44 million. The single-day repurchase amount continues to remain at a high level. On the funding side, the company has also received favorable views from southbound funds. According to the latest data from Wind (as of February 2nd), southbound funds have been net buyers of YIDU TECH for nine consecutive days, with a cumulative net purchase amount of HK$44.97 million. As of February 2nd, southbound funds held approximately 237 million shares of the company, representing a stake of 22.14% and a market value of approximately HK$1.333 billion. The company's continuous repurchases and the steady inflow of southbound funds represent a "double fund endorsement," signaling positive market sentiments. Analysts point out that the positive trends in funding align with the company's recent business fundamentals. Previously, the company has established partnerships with the Shenzhen Nanshan Hospital for "AI+ healthcare management" and has launched a general medical diagnosis and treatment AI assistant in collaboration with the First Affiliated Hospital of Chongqing Medical University. The ongoing repurchases and fund inflows collectively reflect market recognition of the company's business value and strategic execution capabilities.